-transparent.png){kind=logo}
Immunoscintigraphy using radioisotope-labelled monoclonal antibody prepared against osteosarcoma 791T cells was used to detect a primary osteosarcoma. The eight-centimetre tumour was detected using rectilinear scintigraphy of 131I-labelled antibodies. Image enhancement was achieved by subtraction of blood-pool radioactivity labelled with technetium-99m. The ratio of tumour to non-tumour uptake of radioactivity (5:1) suggested that antibody targeting of therapeutic agents is feasible.
Related Publications
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
November 1982,
Lancet (London, England),
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
May 1983,
Journal of neurology, neurosurgery, and psychiatry,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
January 1985,
Medical oncology and tumor pharmacotherapy,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
January 1988,
British journal of neurosurgery,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
February 1983,
British journal of cancer,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
January 1990,
La Chirurgia degli organi di movimento,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
November 1991,
British journal of cancer,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
July 1987,
British journal of cancer,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
May 1981,
British journal of cancer,
P A Farrands, and
A Perkins, and
L Sully, and
J S Hopkins, and
M V Pimm, and
R W Baldwin, and
J D Hardcastle
June 1984,
European journal of cancer & clinical oncology,
